Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

ClinicalTrials.gov ID: NCT01005888

Public ClinicalTrials.gov record NCT01005888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LEVP2005-1/Part B: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) as Prophylactic Treatment to Prevent HAE Attacks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study objective was to determine the safety and efficacy of C1INH-nf for the prevention of acute HAE attacks.

Study identification

NCT ID
NCT01005888
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
26 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2005 (Actual)
Primary completion
Aug 22, 2007 (Actual)
Completion
Aug 22, 2007 (Actual)
Last update posted
Jun 11, 2021

2005 – 2007

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Allergy and Immunology Associates Scottsdale Arizona 85251 —
University of California, San Diego San Diego California 92093-0732 —
Allergy and Asthma Clinical Research, Inc Walnut Creek California 94598 —
Atlanta Allergy and Asthma Clinic Suwanee Georgia 30024 —
Hawaii Pacific Health Research Institute Honolulu Hawaii 96826 —
Welborn Clinic Allergy and Immunology Evansville Indiana 47713 —
Lake Charles Memorial Hospital Lake Charles Louisiana 70601 —
Institute for Asthma and Allergy Wheaton Maryland 20902 —
Libby Clinic Libby Montana 59923 —
Mount Sinai School of Medicine New York New York 10029 —
Nationwide Childrens Hospital Clinical Research Columbus Ohio 43205 —
Allergy Clinic of Tulsa Tulsa Oklahoma 74133 —
Allergy Asthma and Dermatology Research Center Lake Oswego Oregon 97035 —
AARA Research Center Dallas Texas 75231 —
Tyler County Hospital Woodville Texas 75979 —
St. Joseph's Hospital/Cornerstone Healthcare Parkersburg West Virginia 26101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01005888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01005888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →